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Background: Newcastle disease (ND), caused by Newcastle disease virus (NDV), is a devastating disease of poultry
and wild birds. ND is prevented by rigorous biocontainment and vaccination. One potential approach to prevent
spread of the virus is production of birds that show innate resistance to NDV-caused disease. Induced pluripotent
stem cell (iPSC) technology allows adult cells to be reprogrammed into an embryonic stem cell-like state capable of
contributing to live offspring and passing on unique traits in a number of species. Recently, iPSC approaches have
been successfully applied to avian cells. If chicken induced pluripotent stem cells (ciPSCs) are genetically or
epigenetically modified to resist NDV infection, it may be possible to generate ND resistant poultry. There is
limited information on the potential of ciPSCs to be infected by NDV, or the capacity of these cells to become resistant
to infection. The aim of the present work was to assess the characteristics of the interaction between NDV and ciPSCs,
and to develop a selection method that would increase tolerance of these cells to NDV-induced cellular damage.
Results: Results showed that ciPSCs were permissive to infection with NDV, and susceptible to virus-mediated cell
death. Since ciPSCs that survived infection demonstrated the ability to recover quickly, we devised a system to select
surviving cells through multiple infection rounds with NDV. ciPSCs that sustained 9 consecutive infections had a
statistically significant increase in survival (up to 36 times) compared to never-infected ciPSCs upon NDV infection
(tolerant cells). Increased survival was not caused by a loss of permissiveness to NDV replication. RNA sequencing
followed by enrichment pathway analysis showed that numerous metabolic pathways where differentially regulated
between tolerant and never-infected ciPSCs.
Conclusions: Results demonstrate that ciPSCs are permissive to NDV infection and become increasingly tolerant
to NDV under selective pressure, indicating that this system could be applied to study mechanisms of cellular
tolerance to NDV.
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Newcastle disease (ND) is a devastating disease of
domestic poultry that causes severe economic losses
both in developing and developed countries [1]. The
disease is caused by virulent strains of Newcastle disease
virus (NDV), an enveloped virus classified within the
Mononegavirales order, Paramyxoviridae family, Avula-
virus genus [2]. All NDV strains belong to a single sero-
type (avian paramyxovirus serotype 1, APMV-1), and the
virus genome constitutes of a non-segmented, negative
sense RNA molecule of approximately 15.2 Kb, which
encodes for six structural proteins, namely from 3’ to 5’:
nucleoprotein (NP), phosphoprotein (P), matrix (M),
fusion (F), hemagglutinin-neuraminidase (HN), and
polymerase (L) [3]. According to international standards,
NDV strains can be classified as virulent or non-virulent,
based on the intra cerebral pathogenicity index (ICPI),
and on the deduced amino acid sequence of the F pro-
tein at amino acid residues 112 to 117 (cleavage site) [4].
Worldwide control of ND is carried out by costly and
rigorous biocontainment and vaccination programs [1].
NDV vaccines protect birds against clinical signs, how-
ever do not confer sterile immunity, leading to circula-
tion of virulent strains among vaccinated birds [5, 6].
Unrestrained virus circulation leads to virus evolution
and ultimately emergence of new NDV strains [7].
Attempts to select for resistance against NDV in poultry
through traditional breeding strategies have not been
successful [8], and to date no poultry species susceptible
to NDV have been successfully bred for increased resist-
ance against development of ND. Production of poultry
species that are resistant to NDV infection at the cellular
level could hypothetically lead to the development of
new means of controlling ND, especially in areas where
ND is endemic and difficult to eradicate.
Induced pluripotent stem cell (iPSC) technology is a
system by which adult cells such as skin fibroblast can
be reprogrammed into an embryonic state, almost iden-
tical to embryonic stem cells. iPSCs can be utilized to
generate animals with unique genetic and epigenetic
traits as they can form germline competent chimeric ani-
mals and ultimately offspring with the specified pheno-
types [9, 10]. iPSC technology has been successfully
applied to mammalian species, including humans [9–12],
and it has garnered success with avian species as well,
such as chickens and quails [13–15]. Chicken induced
pluripotent stem cells (ciPSCs) display characteristics indi-
cative of a stem cell state including morphological and
functional characteristic [13, 14, 16]. ciPSCs have demon-
strable alkaline phosphatase enzymatic activity, and posi-
tive cytochemical staining for periodic acid-schiff (PAS)
[13, 14, 16], consistent with stem cell staining characteris-
tics [17]. As the most stringent proof of pluripotency,
ciPSCs can be used to generate chimeric birds bytransplantation into the embryo at early stages of embryo-
genesis, as shown with chicken-quails and chicken-
chicken chimeras [13, 14]. Chimeric animals can then be
bred to produce offspring with specific traits, as demon-
strated by our group in other livestock species [15, 18].
Further, our laboratory has demonstrated that ciPSCs can
undergo in vitro differentiation into early primordial germ
cells (PGCs), which are capable of migrating to the gonads
when injected into a developing embryo [19]. These
ciPSC-PGCs can produce viable spermatozoa or oocytes,
potentially leading to generation of fully transgenic off-
spring though crossbreeding of chimeric birds. With a
similar mechanism, ciPSCs that are resistant to NDV
could be used to generate transgenic birds that maintain
the resistance trait in every tissue of the body.
Complete cellular resistance to NDV infection has
been demonstrated in mammalian cells lacking specific
sialylated moieties (mainly gangliosides, and N-syalilated
glycoproteins) on the cell surface (absence of receptors)
[20], while increased tolerance to NDV-induced cell
death in cell culture has been associated with the presence
of specific intracellular pathogen sensors – such as
Retinoic Acid-Inducible Gene I (RIG-I) [21, 22];
increased type-I interferon response [23, 24]; and
activity of the Mx protein family [25–27]. Also viral
interference, although not a cellular resistance per se,
inhibits NDV superinfection [28–30]. For the purposes of
this study, the term tolerance was defined as the decreased
susceptibility of ciPSCs to NDV-induced cell death, while
still permissive to infection. In this context, “tolerance”
differs from “resistance” to virus infection, which is con-
sidered as the total inability of the virus to infect cells
(true resistance, receptor-mediated).
Infection of non-pluripotent cell lines with viruses at
high multiplicity - without prior mutagenesis approach -
has led to spontaneous selection of cells that are
resistant or less susceptible to the cytolytic effect of the
challenge virus. This has been reported for murine
FM3A cells infected with NDV [31], porcine kidney cells
line (ESK-R) infected with Influenza Virus [32]; hamster
BHK-21 or CHO-K1 cells infected with murine enceph-
alomyelitis virus or Ebola virus, respectively [33, 34]; canine
(MDCK), swine (PK-15) and rabbit (RK-13) cell lines
infected with cytolytic strains of Bovine Viral Diarrhea
Virus (BVDV) [35]. A similar approach could theoret-
ically produce spontaneously-induced resistance in
ciPSCs, or generate ciPSCs less susceptible (tolerant)
to NDV-induced cellular damage.
The aim of the present work was to evaluate the
susceptibility of ciPSCs to infection with NDV of dif-
ferent virulence, and to establish a screening/selection
method to naturally derive ciPSCs that are tolerant to
NDV infection. Preliminary characterization of the
interaction between NDV and ciPSCs, as well as
Fig. 1 NDV Successfully replicates in ciPSCs. Multi-cycle replication
kinetics of NDV in BA3NI ciPSCs, compared to DF-1 cells. Both NDV
strains rZJ1-GFP (a) and rLS-RFP (b) are able to replicate in BA3NI
cells and to be released in the supernatant at high titers. For each
experiment, n = 3. Titers are represented as mean ± SD standard de-
viation (SD). *indicates significant differences between averaged
titers at each time point (two-way ANOVA for repeated measures,
Sidak’s test for multiple comparisons, p < 0.05)
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the opportunity to better characterize these cells and
fits within the overarching effort to generate ND-
resistant chickens.
Results
NDV replicates in ciPSCs
Chicken iPSCs were derived as previously described
[16]. ciPSCs had typical characteristics of a stem cell
fate: large nucleus to cytoplasm ratio, large nucleoli,
positive cytochemical reaction for PAS and Alkaline
Phosphatase, and expression of embryonic stem cell
markers as shown by RT-PCR and immunocytochemistry
[16]. Derived cells were named BA3NI, and expanded for
the purpose of the experiments in this work.
To evaluate the ability of NDV to replicate in ciPSCs,
multi-cycle virus growth curves were performed in
BA3NI cells infected with both non-virulent (recom-
binant LaSota-RFP, (rLS-RFP) [29]) and virulent
recombinant ZJ1-GFP (rZJ1-GFP) [36] NDV strains,
and compared to growth in DF-1 cells (immortalized
chicken fibroblast cells [37]). Briefly, both BA3NI and
DF-1 cells were plated into 6-well-plates and infected
with each virus at a multiplicity of infection (MOI) of
0.01. Virus growth at established time points [6, 12,
24, 36, 48, 72 h post-infection (hpi)] was measured by
titration of the virus in the supernatant through limiting
dilution using DF-1 cells, and expressed as Tissue Culture
Infectious Dose 50% (TCID50)/ml. Titration results (Fig. 1,
panel a and b) showed that the two viruses grew similarly
in both ciPSCs and DF-1 cells up to 48 hpi, however, at 72
hpi rZJ1-GFP strain grew at significantly higher titers in
ciPSCs compared to DF-1 cells (two-way ANOVA, Sidak’s
test for multiple comparisons). As expected, the virulent
strain showed a higher yield (2–3 logarithmic units) than
the non-virulent strain in the same cell line. At 72 hpi,
yields (mean ± SD, expressed as log10 TCID50 units/ml) in
ciPSCs were 8.4 (+0.08, −0.10) and 5.36 (+0.22, −0.30) for
rZJ1-GFP and rLS-RFP, respectively, while for DF-1 cells
were 7.57 (+0.13, −0.17) and 5.32 (+0.25, −0.39) for rZJ1-
GFP and rLS-RFP, respectively. Taken together, these data
show that NDV is able to replicate in pluripotent BA3NI
cells, slightly more efficiently than in DF-1 cells.
NDV effectively induces cell death in ciPSCs
The ability of the non-virulent rLS-RFP to induce cell
death in BA3NI was assessed utilizing a high MOI.
Briefly, BA3NI were plated at a density of 1.6×105 cells/
well in a 6-well-plate (time point: D-1) and the following
day (24 h) infected with rLS-RFP at MOI = 50 (time
point: D0). At 24 hpi, cells started showing severe cyto-
pathic effect characterized by rounding and detachment
from the plate (Fig. 2, panel a), which progressed at 72
hpi (Fig. 2, panel b). These changes were associated withintense fluorescence at 24 hpi (Fig. 2, panel c), which sub-
sided at 72 hpi in viable cells (Fig. 2, panel d). Surviving
cells at 72 hpi showed no signs of cytopathic effect,
although some residual fluorescence could be observed
(Fig. 2, panels i–j). A representative count of infected
BA3NI cells compared to non-infected cells at 72 hpi
(time point: D3) is presented (Fig. 2, panel k).
Based on five biological replicates, the percentage of
viable BA3NI cells after infection, as counted at 72 hpi,
was 15.52% ± 10.50 (mean ± SD) of the number of cells
counted at the time of infection (D0), and 2.02% ± 2.25%
(mean ± SD) of the control (non-infected) cells at D3
(72 hpi). Taken together, these data show that high
MOI of rLS-RFP can be used to effectively induce cell
death and select BA3NI cells.
Fig. 2 NDV effectively induces cell death in ciPSCs. Infected BA3NI cells show increasingly severe cytopathic effect from 24 hpi (panel a) to 72 hpi
(panels b), which is associated with RFP fluorescence (panels c and d). Non-infected controls at the same time are confluent (panels e and f) and
do not show RFP fluorescence (panels g and h). At 72 hpi, the few surviving cells left do not show cytopathic effect (Panel i). In infected cells,
fluorescence has the highest intensity at 24 hpi, and subsides at 72 hpi in surviving cells (panel d and j). A representative counting of infected
compared to non-infected BA3NI cells is shown in the graph (panel k). D-1, day of cell plating; D0, time of infection; D3, 72 hpi (day 3 post infection).
For each experiment, n = 3. Counting values are expressed as mean ± SD. *indicates significant differences between average number of cells at each
time point (two-way ANOVA for repeated measurements, Sidak’s test for multiple comparisons, p < 0.05)
Susta et al. Virology Journal  (2016) 13:205 Page 4 of 15ciPSCs demonstrate rapid recovery after infection with NDV
The ability of BA3NI to recover after infection was
assessed by counting the amount of viable cells at day 6post-infection (144 hpi). BA3NI and DF-1 were plated into
6-well plates and infected at high MOI as described in the
previous section. The number of viable cells present in
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hpi. Results showed that BA3NI and DF-1 cells recover at
very different rates after infection. After markedly declin-
ing in number at 72 hpi, BA3NI cells were able to clear
the virus and to proliferate as single large colonies that
eventually became confluent by 144 hpi (Fig. 3, panel a).
Conversely, DF-1 cells failed to recover and proliferate by
144 hpi (Fig. 3, panel c). Additionally, ciPSCs were able to
clear the RFP fluorescence (Fig. 3, panel b), whereas DF-1
remained intensely fluorescent (Fig. 3, panel d). A repre-
sentative count of the differences in recovery abilities be-
tween BA3NI and DF-1 is reported in (Fig. 3, panel e).
Repeated NDV selection decreases susceptibility of ciPSC
to NDV-induced cell death
Given the ability of ciPSCs to be infected by NDV and
to quickly recover after infection, a screening systemFig. 3 ciPSCs demonstrate rapid recovery after infection with NDV. Photomicro
post-infection (144 hpi) with rLS-RFP at MOI = 50. BA3NI appear as large conflu
infection. Panels a–d, magnification 20X; insets, magnification 10X; panels a, c b
DF-1 compared to infected BA3NI is shown in the graph (panel e). D-1, day of
144 hpi (day 6 post-infection). For each experiment, n= 3. Counting values are e
number of cells at each time point (two-way ANOVA for repeated measuremenwas devised to test the hypothesis that ciPSCs could
become incrementally more tolerant (less susceptible) to
NDV-induced cell death upon multiple rounds of infec-
tion/selection. Tolerance, for the purpose of our study,
is a quantitative character assessed in a population of
infected cells, and it is quantified by calculating the ratio
between amount of viable cells present at 72 hpi (D3)
and those present at the time of infection (0 h, D0);
the higher the ratio, the more tolerant cells are
deemed. Therefore, increased tolerance encompasses
both the ability of cells to withstand virus-induced cell
death, and to recover from it (clearing the infection and
replicating).
BA3NI cells were infected with rLS-RFP (MOI = 50),
and surviving cells were propagated for the next infec-
tion; this was repeated nine times (see methods). After
each round, surviving cells were named with increasinggraphs showing BA3NI (panels a, b) and DF-1 (panels c, d) cells at day 6
ent colonies, as opposed to DF-1, which do not increase in number after
right field, b, d red fluorescence. A representative counting of infected
cell plating; D0, time of infection; D3, 72 hpi (day 3 post-infection); D6,
xpressed as mean ± SD. *indicates significant differences between average
ts, Sidak’s test for multiple comparisons, p< 0.05)
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that survived and were expanded after one round of
infection: from round 0 to 1). After every 3 rounds of
infection (rounds 3, 6, and 9), subsets of selected cells
were used to assess putative progression of tolerance by
counting surviving cells at 72 hpi. A schematic represen-
tation of the selection process is presented in Fig. 4.
Progression of tolerance between different rounds of
infection was evaluated by normalizing the survival data
for each round of infection to the basal level of tolerance
of the naïve cells (n values, see material and methods).
BA3NI-I3 (3rd round of infection), BA3NI-I6-clone (C)1
and C2 (the two clones sorted after the 6th round of
infection, see next section) and BA3NI-I9-C1 and C2
(after 9th round of infection) showed increased resistance,
when compared to never-infected BA3NI-I0 (n values:
BA3NI-I3, 2.34 ± 0.26; BA3NI-I6-C1, 12.61 ± 1.31;
BA3NI-I6-C2, 7.94 ± 1.95; BA3NI-I9-C1, 36.24 ± 20.30;
BA3NI-I9-C2, 30.26 ± 7.90; mean ± SD) (Fig. 5). Using the
non-parametric Kruskal-Wallis test followed by the
Dunn’s test for multiple comparisons, differences in sur-
vival between BA3NI-I3 and B3NI-I9-C1 and C2 were
considered to be statistically significant (p < 0.05). Repre-
sentative pictures and cell counts of BA3NI-I9-C1 and C2
(selected for 9 times) upon infection are showed in Fig. 6.
Upon infection with rLS-RFP at MOI = 50, at 72 hpi
BA3NI-I9-C1 and C2 showed increased numbers of
surviving cells compared to infected BA3NI-I0, as de-
termined by microscopic evaluation (Fig. 6, panels a–f )
and counting (Fig. 6, panel g). Noticeably, even as cells
became progressively more tolerant to NDV infection,
the virus was still able to infect the cells at each round,
as shown by microscopic observation under fluores-
cence (Fig. 6, panels b, d).Fig. 4 Iterative process for ciPSCs selection. At D-1 cells were plated at 1.6X10
LS-RFP at MOI = 50. At D3 (3 days post infection [dpi]), cells were washed, exp
infection, a representative sample of the selected cells was infected with theNine-time selected ciPSCs are devoid of NDV
After the 6th round of infection, cells became persist-
ently infected (BA3NI-I6-PI) and continuously expressed
RFP fluorescence. To select for RFP negative cells, and
to continue the selection process, non-fluorescent cells
were sorted (Fluorescence Activated Cells [FACs] sort-
ing) and 2 clonally-derived cell lines were propagated
(BA3NI-I6-C1 and C2) to continue the selection to the
9th round of infection (see material and methods). At
the end of the selection process, non-infected BA3NI-I9-
C1 and C2 did not show fluorescence under microscopic
observation. To confirm absence of residual NDV after
the process of infection/selection, RT-PCR for NDV NP
and L genes was performed on cellular RNA extracted
from BA3NI-I9-C1 and C2 (the clones resulted at the
end of the selection process, see material and methods).
Expected product size was 1306 bp and 1761 bp for NP
and L gene, respectively. Results showed absence of
cDNA amplicons for RNA samples extracted from
BA3NI-I9-C1, C2 and BA3NI-I0 cells (Fig. 7). Expected
bands were observed when RNA from BA3NI-I6-PI cells
was used as template. To confirm the negative RT-PCR
results, a virus isolation (VI) test was performed on
BA3NI-I9-C1 and C2 pellets (one passage in egg) [38, 39].
Negative results for VI (data not shown) were in agree-
ment with the RT-PCR results, and confirmed that
cells at the end of the selection process were devoid of
residual virus.
Increased tolerance to virus-induced cell death in selected
ciPSCs is not caused by decreased permissiveness to NDV
infection
To evaluate if the increased tolerance to virus-induced
cell death observed with BA3NI-I9 C1 and C2 was5 cells/well, and infected at D0 (time of infection, TOI) with NDV strain
anded and propagated for another round of infection. Every 3 rounds of
same methodology to assess putative progression of tolerance
Fig. 5 Repeated NDV selection decreases susceptibility of ciPSC to
NDV-induced cell death. Progression of tolerance to rLS-RFP challenge
(MOI = 50) between different rounds of infection (round 3, I3; round 6,
I6; round 9, I9). C1 and C2 indicate the two clones sorted from
the persistently infected cells (I6-PI). Survival data were obtained
by normalizing to the basal level of tolerance of naïve cells (n values, see
material and methods). BA3NI-I3, I6 and I9 showed increased tolerance
with progressive rounds of infection, compared to never-infected
BA3NI-I0 (level 0). For BA3NI-I9-C1 and C2, n = 9; for the other
groups, n = 3. n values are expressed as mean ± SD. Letters
indicate significant differences between groups (Kruskal-Wallis
and Dunn’s method for multiple comparisons, p < 0.05)
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multi-cycle growth curves were performed on BA3NI-I0
and BA3NI-I9-C1 and C2 with non-virulent and virulent
NDV strains rLS-RFP and rZJ1-GFP, as described previ-
ously. At 72hpi, strains rLS-RFP and rZJ1-GFP yielded
higher titers in BA3NI-I9-C1 and C2, respectively, com-
pared to BA3NI-I0 cells. At other time points (6, 12, 24,
36, 48hpi) no differences in virus yield between cell lines
were observed (Fig. 8, panel a and b). These data indicate
that increased tolerance of BA3NI-I9-C1 and C2 cells to
NDV infection was not caused by a decreased permissive-
ness to infection, since virus yield in BA3NI-C1 or C2 is
slightly higher than in naïve cells (BA3NI-I0).
Differential gene expression between BA3NI-I0 and BA3NI-I9
RNA sequencing (RNA-seq) was used to investigate the
effect of NDV selection on the BA3NI transcriptome,
comparing the naïve BA3NI-I0, BA3NI-I9-C1 and
BA3NI-I6-PI (persistently infected cells). Extracted RNA
(in biological triplicates) for each cell line was reverse-
transcribed with random priming, and sequenced using
an Illumina 1.9 platform. Table 1 shows the starting and
ending number of reads with the minimum average
quality per sample, and the average coverage provided
by each sample measured against the reference genome
along with the range of read-lengths after the filtering
process. Paired ends were matched, and only lengths
greater than or equal to 75 nucleotides were used in thefollowing analyses. Differential RNA expression was ana-
lyzed using the Tuxedo Suite [40–42] software, with a
0.05 significance cutoff. Results were summarized using
cummeRbund software package, and false discovery rate,
as implemented in Cuffdiff [41, 43], was used to correct
for multiple comparisons. The analysis identified 62, 869
and 1009 differentially expressed genes between BA3NI-
I0 and I6, BA3NI-I6 and I9, and BA3NI-I0 and I9,
respectively (see Additional file 1: Tables S1, Additional
file 2: Table S2 and Additional file 3: Table S3 for details,
gene names and annotations). Pathway analysis was
carried out with PathView analysis using the KEGG
pathways. Significantly upregulated and downregulated
pathways between comparisons are reported in Table 2.
Discussion
In the present work we demonstrated the susceptibility
of ciPSCs to infection with low and high virulence NDV
strains, and established a selection protocol to generate
ciPSCs increasingly tolerant to NDV-induced cell death.
Our data demonstrated that ciPSCs can support pro-
ductive infection with virulent and non-virulent NDV
strains, and viral release in the supernatant to levels
higher than those reached in an immortalized fibroblast
cell line (DF-1). This is in agreement to what recently
reported with a different ciPSC line created utilizing the
same technology [44], suggesting that susceptibility to
NDV infection in ciPSCs is likely a well-conserved
feature. However, permissiveness to virus replication is a
characteristic that avian stem cells may not share with
other species. In fact, human and murine pluripotent
stem cells were non-permissive to infection with
multiple viruses, such as hepatitis C virus (HCV) [45],
varicella zoster virus (VZV) [46], and only moderately
permissive to Influenza A virus and human Herpes-
Simplex virus-1 [47]. At least for HCV and VZV, permis-
siveness to infection appeared to increase with the
degree of cellular differentiation [45, 46]. This might
suggest that, contrary to what observed with other
viruses, NDV infection is not particularly restricted by
the degree of cellular differentiation, or that chicken
iPSCs have specific characteristics that are suitable for
virus growth. The mechanism underlying this fast recovery
of ciPSCs, in contrast to DF-1, after infection with high
MOI remains to be elucidated.
Selection of ciPSCs after 9 rounds of infection allowed
for the derivation of a ciPSCs line that is up to 36 times
more tolerant to NDV infection than naïve ciPSCs. Des-
pite increased tolerance, selected cells remained permis-
sive to NDV infection. Both rLS-RFP and rZJ1-GFP
grew at higher titers in 9-time selected compared to
never-selected ciPSCs, possibly reflecting the higher
number of cells available for virus replication at later
time points. Since selected cells were still permissive to
Fig. 6 Multiple rounds of selection with NDV decrease susceptibility of BA3NI to NDV cytolytic effect at 72 hpi. After nine rounds of selection,
BA3NI-C1-I9 (a, b) and BA3NI-C2-I9 (c, d) show decreased susceptibility to NDV cytolytic effect compared to BA3NI-I0 (never infected cells) (e, f).
Cell counting shows that BA3NI-C1-I9 and BA3NI-C2-I9 have roughly 36 and 45 times more cells than naïve infected cells at 72hpi (g). D-1, day of
cell plating; D0, time of infection; D3, 72hpi (day 3 post infection). For each experiment, n= 3. Counting values are expressed as mean ± SD. Letters indicate
significantly different values at the same time point (two-way ANOVA for repeated measurements, Tukey’s test for multiple comparisons, p< 0.05)
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cytopathic effect, we opted to use the operational defin-
ition of tolerance, rather than the term resistance.
The mechanisms of increased tolerance in selected
cells are unclear and await further characterization. Pro-
gression of tolerance in this study was evaluated by
assessing the number of cells present in the plate at 72
hpi compared to the number of cells present at the time
of infection at 0 hrs. Therefore, increased tolerance can
be a combination of decreased susceptibility to cell-death, or heightened recovery rate after infection,
including virus clearance and replicative efficacy. Doubling
time in nine-time selected ciPSCs lines, however, did not
appear to be shorter compared to naïve ciPSCs (data not
shown), suggesting that a faster replication is not the main
mechanism leading to a more tolerant state.
RNA sequencing showed that several genes are differ-
entially expressed between selected and non-selected
cells. Pathway analysis revealed that most of the genes
upregulated in BA3NI-I9-C1 included those involved in
Fig. 7 Nine-time selected BA3NI are devoid of NDV. Both BA3NI-I9-C1 and C2 (nine-time infected) are devoid of NDV genetic material, as assessed
by RT-PCR for NDV Nucleoprotein (NP) and Polymerase (L) genes. See text for explanation
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cellular proliferation, apoptosis, cell adhesion and signal-
ling, and regulation of the cytoskeleton. In agreement
with our results, a recent study showed that basic cellu-
lar processes were also differentially expressed in the
lungs of partially resistant Fayoumi chickens infected
with AIV, when compared to fully susceptible Leghorn
chickens [48]. In particular, genes involved in actin
filament-based movement and multicellular organismal
process were upregulated, while those involved in cell
adhesions (CAM) and immune response were down-
regulated [48].
During the selection process, ciPSCs became persistently
infected after the 6th round of infection. It is possible that
the high MOI used during the selection process might
have led to production of defective interfering particles
facilitating the establishment of a persistent infection [28].
However, sorting of non-fluorescent cells was sufficient
to rescue clones that were not persistently infected,
demonstrating that increased tolerance observed with
BA3NI-I9-C1 and C2 cells was not the consequence of
viral interference.
As they have the potential to produce chimeric and
fully transgenic birds [19], ciPCSc that are either resistant
or less susceptible to NDV infection could be used to pro-
duce transgenic birds that are resistant to ND at a cellular
level. The present study is a preliminary investigation
toward this direction. Our results show that increased
tolerance of ciPSCs is a complex mechanism, and it is
difficult to predict if this trait could be maintained
through development without being silenced and be
successfully passed onto offspring. Future studies shouldaim at inducing higher levels of resistance in selected cells,
possibly using transgenic approaches where a single locus
(e.g., small interfering RNA against virus genes) could
confer resistance with a simpler mechanism. In this study
a transgenic approach was avoided, as spontaneously re-
sistant cells were sought through multiple selection events.
Conclusions
In this study, we have demonstrated that ciPSCs are sus-
ceptible to infection with high- and low-virulence NDV,
and have developed a system for derivation of cell lines
that are incrementally more tolerant to NDV infection
through multiple rounds of infection and selection. The
system described in this study could be utilized to study
host mechanism of tolerance to infection against NDV
in vitro, and to develop new platforms for production of




Detailed methodology for derivation of ciPSCs from
CEFs are reported elsewhere [16]. Briefly, primary
chicken embryo fibroblasts from black Australorp chick-
ens embryos were reprogrammed with Minicircle vec-
tors expressing human transcription factors POUF51,
NANOG51, SOX2, and LIN28. BA3NI cells were main-
tained in cKSR (knock-out serum replacement) media
[DMEM/F12 (Gibco), supplemented with 20% knockout
serum replacement (KSR; Gibco), 2 mM L-glutamine
(Gibco), 0.1 mM nonessential amino acids (Gibco), 1xPen/
strep(Gibco), 0.1 mM β-mercaptoethanol (Sigma- Aldrich),
Fig. 8 Nine-time selected ciPSCs are permissive to NDV replication.
To determine if BA3NI at the end of the selection process were less
permissive than naïve (never selected) BA3NI cells, multi-cycle
growth curves were performed in BA3NI-C1 and C2 (selected) and
BA3NI-I0 (naïve) with both virulent and non-virulent NDV strain rZJ1-GFP
(a) and rLS-RFP (b). n = 3, titers expressed as mean ± SD. *indicates
significant differences between average titers at each time point
(two-way ANOVA for repeated measures, Tukey’s test for multiple
comparisons, p < 0.05)
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Systems)] in pre-coated plates to increase cell adhesion
[Matrigel (BD Biosciences); diluted 1:100 in DMEM/F12].
For passaging, cells were dissociated with Accutase (In-
novative Life Technologies). DF-1 cells (chicken fibroblast
cells line - ATCC CRL 12203) were maintained in fibroblast
media [Dulbecco’s modified Eagle’s medium, high glucoseTable 1 Summary statistics of the sequencing reads performed in th
Sample Initial read count Final read count (%)
BA3NI-I0 1,155,428 817,773 (70.8%)
BA3NI-I6-PI 1,052,378 793,149 (75.4%)
BA3NI-I9 1,083,813 799,653 (73.8%)
Reads were preprocessed by trimming 15 nucleotides from the 5’ end, and then by
Phred score of 25. This was followed by filtering reads such that 80% or more nucleoti(Hyclone) with 10% fetal bovine serum (Hyclone), 4 mM L-
glutamine (Gibco) and 1x Pen/strep (Gibco)], and dissoci-
ated upon confluence with 0.05% trypsin. All cells were
maintained at 37C and 5% CO2.
Eggs and chickens
Embryonated chicken eggs utilized for production of
virus stock and virus isolation were obtained from the
Southeast Poultry Research Laboratory (SEPRL) Specific
Pathogen Free (SPF) white Leghorn flock.Viruses
Recombinant NDV strains ZJ1-GFP (rZJ1-GFP) and
LaSota-RFP (rLS-RFP) were obtained from the SEPRL
virus repository. rZJ1-GFP is a virulent strain with ICPI
of 1.88 carrying the Green Fluorescent Protein (GFP)
gene between the P and M genes [36]. rLS-RFP is a len-
togenic NDV with ICPI of 0.0 carrying a Red Fluores-
cent Protein gene between the F and the HN genes [29].
Each virus expresses the respective fluorescent genes
upon infection in cell cultures. Insertion of the extra
gene cassette in the virus genomes did not induce sig-
nificant decrease of virus fitness compared to parental
strains, as assessed by multi-cycle growth curves in cell
culture [29, 36]. To produce virus stock, viruses were
inoculated in the chorioallantoic cavity of 9 to 10 day-
old embryonating SPF eggs. Dead eggs, or eggs surviving
after 5 days of incubation were chilled at 4 C for 24 h,
and hemagglutination (HA) - positive allantoic fluid was
extracted, pooled, clarified by centrifugation (10’ at
5000 rpm), and stored in 1 ml aliquots at -80C [38, 39].
Virus stock was titered in DF-1 cells in 96-well plates
through limiting dilutions, and titer was expressed as
Tissue Culture Infection Dose 50% (TCID50)/ml using
the Spearman-Karber method [49].
Growth Curves in ciPSCs
To assess the ability of NDV to replicate in ciPSCs, a
multi-cycle growth assay (multiplicity of infection,
MOI = 0.01) was performed in BA3NI-I0 and compared
to NDV replication in DF-1 cells. Additionally, growth
curves were performed to compare virus growth in
BA3NI-I0 and BA3NI-I9-C1 and C2 after selection. Cells
(BA3NI-I, BA3NI-I9-C1 and C2 and DF-1) were plated in
triplicate into 6-well-plates at a density of 7×105 cells/well.e Illumina platform




trimming both ends using a sliding window of 3 nucleotides and an average
des had quality score over 20 and removing all reads with length less than 75
Table 2 List of pathways upregulated and downregulated between selected, persistently infected, and naïve BA3NI ciPSCs
BA3NI-I9-C1 compared to BA3NI-I0 BA3NI-I6 compared to BA3NI-I9-C1 BA3NI-I6 compared to BA3NI-I0
Upregulated Downregulated Upregulated Downregulated Upregulated Downregulated
Al, ASP, GLU Metabolism Fatty Acid Elongation Fatty Acid Elongation Al, ASP, GLU Metabolism Ribosome Biogenesis
in Eukaryotes





Lysine degradation Oxidative Phosphorylation Oxidative Phosphorylation Inositol Phosphate Metabolism
Inositol Phosphate
Metabolism
Pyrimidine Metabolism Pyrimidine Metabolism mRNA surveillance Pathway
MAPK Signalling
Pathway
Glutathione Metabolism Arginin and Proline
Metabolism
MAPK Signalling Pathway
ERBB Signalling Pathway N-Glycan Biosynthesis Tyrosine Metabolism ERBB Signalling Pathway
FOXO Signalling
Pathway
GPI-anchor Biosynthesis Glutathione Metabolism FOXO Signalling Pathway
PI Signalling System Ribosome Biogenesis in
Eukaryotes
N-Glycan Biosynthesis PI Signalling System





RNA polymerase GPI Anchor Biosynthesis Ubiquitin-Mediated Proteolysis





Proteasome Metabolism of Xenobiotics by
Cytochrome P450
mTOR Signalling Pathway











Protein Export Vascular smooth muscle
contraction





Phagosome Protein Processing in
Endoplasmic reticulum
Dorso-Ventral Axis Formation
VEGF Signalling Pathway Cardiac Muscle Contraction Lysosome VEGF Signalling Pathway
Focal Adhesion Cell Adhesion Molecules Cardiac Muscle Contraction Focal Adhesion
Tight Junction Cell Adhesion Molecules Adherens Junction
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with 0.01 MOI of either rLS-RFP or rZJ1-GFP diluted in
1%-serum fibroblast media or 5% KSR media (1 mlinoculum/well), respectively for infection of DF-1 or ciPS
cells. After 1 h absorption, cells were washed three times
with PBS and then incubated with maintenance fibroblast
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hpi, 200 μL of supernatant were collected and replaced
with fresh media. The amount of virus in the supernatant
samples was titrated in DF-1 cells using 96-well-plates
through limiting dilutions, and expressed as TCID50/ml
using the Spearman-Karber method [49]. For infection
with rLS-RFP, maintenance media during infection was
supplemented with 8.5 μg/ml porcine trypsin (Sigma), to
allow cleavage of the fusion protein and multiple cycles of
infection [50]. Concentration of trypsin was optimized in
preliminary experiments to increase virus production and
minimize any possible cell damage; a concentration of
8.5 μg/ml did not cause detachment or negatively affect
viability of ciPSCs or DF-1 cells (data not shown).
Assessment of cytolytic effect of NDV on ciPSCs
Preliminary experiments were carried out to optimize
the best conditions to assure highest levels of NDV-
induced ciPSCs death. Marked cell death was observed
at 72 hpi using a high MOI (=50) in combination with
low cell density (initial plating density =1.6×105 cells/35-
mm dish). These conditions were maintained for all the
infection procedures of this work. Briefly, cells were
infected in triplicate with rLS-RFP at MOI = 50, in 6-well-
plate format. Cells were plated at 1.6×105 cells/well, and
after 24 h cells were infected with rLS-RFP diluted in 5%
KSR, as described above. After 1 h absorption, the infec-
tious inoculum was discarded and replaced with cKSR.
Three wells were used as mock-infected control and
treated with 1 ml of 5% KSR without virus. Photomicro-
graphs (Nikon Eclipse TE300, SPOT Software 5.0) were
taken every 24, 48, and 72 hpi. To assess the amount of
remaining cells after infection, counting was performed at
72 hpi, as follows. Wells were washed with PBS and adher-
ent cells were dissociated with 1 ml Accutase (Innovative
Cells Technologies) for 4 min at 37C. After neutralization
of accutase with 1 ml of KSR media, cells were transferred
in conical tubes and centrifuged at 1400 rpm for 5 min.
Cell pellet was resuspended with 300 μL or 500 μL main-
tenance media (depending on the amount of cells), and
the number of viable cells was determined with an auto-
mated cell counter (Nexcelom Bioscience Cellometer
Auto T4), using 1:1 staining with 0.02% Trypan Blue solu-
tion (Sigma) for viability assessment.
Assessment of recovery after NDV infection
The ability of BA3NI, compared to DF-1, to recover
after infection was assessed by counting cells at 72 and
144 hpi. BA3NI-I0 and DF-1 were plated in triplicate
into 6-well plates at 1.6×105 cells/well, and after 24 h
infected with rLS-RFP at MOI = 50, as described above.
At the time of infection, 3 extra well for each cell line
were counted and averaged to effectively calculate the
exact MOI. Mock infected DF-1 and BA3NI cells wereincubated with reduced serum media, as described
above. At 72 and 144 hpi, 3 wells for each cell lines
(both mock and infected) were counted using the
Nexcelom automatic counter, as described above.
Development of a screening system to select ciPSCs after
multiple rounds of infection with rLS-RFP NDV
Based on the ability of NDV to cause cytolytic effect in
ciPSCs, a screening system was developed to assess the
ability of ciPSCs to become incrementally tolerant to
NDV upon multiple rounds of infection/selection (Fig. 4).
The day before infection (D-1), BA3NI cells that were
never infected previously (BA3NI-Infection (I) 0) were
plated at 1.6X105 cells/well in a 6-well-plate format. The
following day (time of infection, TOI, D0) cells were
infected with rLS-RFP at MOI = 50, as described above.
At 72 hpi (end of selection, D3), cells were washed with
PBS, expanded and passaged until no observable red
fluorescence was detectable under microscopic observa-
tion. Cells rescued after each round of infection were
named with increasing cardinal numbers (i.e., BA3NI-I1
indicates those cells that survived and were expanded
after one round of infection). Cells expanded from the
previous round of infection were then plated and
infected as described. Every 3 rounds of infections
(rounds 3, 6, and 9) a batch of selected cells was used to
assess putative progression of tolerance by counting sur-
viving cells at 72 hpi with the Nexcelom automated
counter, as described in the previous section.
Tolerance was calculated by normalizing the number
of remaining infected cells at 72 hpi (D3), over the num-
ber of cells at the time of infection (D0), which was dir-
ectly counted to assess the correct MOI at the time of
infection. To evaluate the progression of tolerance
between different rounds of infection, and to decrease
inter-experimental variability, the normalized values of
tolerance of BA3NI-I3, I6 and I9 derived from each
experiment were divided to the normalized baseline tol-
erance values of the BA3NI-I0 controls that was run
in parallel each time. These double-normalized values (n
values) were compared between each other (Fig. 5).
Persistent infection and FAC sorting
After the 6th round of infection, BA3NI-I6 became per-
sistently infected (PI). In order to eliminate the virus
from the cell population and to proceed in the screening
process, the non-fluorescent cells were separated by
FAC sorting. Briefly, BA3NI-I6 cells were dissociated
with Accutase, centrifuged for 5’ at 1400 rpm, and
washed with PBS twice in order to obtain a final concen-
tration of about 1×106 cells/ml. Resuspended cells in
PBS were sorted using a Beckman Coulter MoFlo XDP
machine, gated for non-fluorescent cells. Of the several
colonies that were negative for RFP, two were expanded
Susta et al. Virology Journal  (2016) 13:205 Page 13 of 15(BA3NI-I6-C1 and C2), and underwent the selection
process through rounds 6 to 9.
RNA extraction and RT-PCR
To determine the presence of NDV in cells that under-
went the whole selection process (BA3NI-I9-C1 and
C2), RT-PCR for two NDV genes (NP, genomic position
43–1349; and L, genomic positions 13338–15099) was
performed on total RNA. Cellular RNA was extracted as
standard protocols using a phenol-chloroform system.
RT-PCR was carried out using the SuperScript III One-
Step RT-PCR System with Platinum Taq DNA polymer-
ase kit (Invitrogen, Carlsbad, CA). Primer sequences are
available upon request.
Virus isolation from ciPSCs
To determine the presence of NDV in ciPSCs that were
persistently infected, and underwent 9 rounds of infec-
tion/selection, VI was performed on BA3NI-I9-C1 and
BA3NI-I9-C2, using BA3NI-I0 as negative control. Cells
from one confluent 100 mm dish for each cell line were
harvested by dissociation with Accutase and centrifuged
at 1400 rpm for 5 min after neutralization with cKSR
media. Supernatant was discarded; the resulting cell
pellet resuspended in 1 ml cKSR media, and the number
of cells/ml was counted (Nexcelom automated counter).
To free cell-associated virus, cells were freeze-thawed
three times at -80C, and treated with oscillating sonica-
tor for 2 min on ice. The homogenized pellet was used
to perform virus isolation and titration in eggs, using
standard methods [38, 39].
Deep Sequencing data and differential gene expression
between BA3NI-I0, BA3NI-I6, and BA3NI-I9
RNA-Seq data assembly and properties
RNA was extracted in biological triplicate from 3×106
BA3NI-I0, BA3NI-I6-PI, and BA3NI-I9-C1 cells using
the with RNeasy Mini kit (Qiagen), following the manufac-
turer protocol. RNA sample quality was assessed through a
Bioanalyzer (Agilent). RNA libraries were created from each
RNA sample, as follows. Starting with total RNA, first
strand cDNA amplification was performed using Oilgo(dT)
oligomers. A cDNA library was then created using random
hexamer primers, and millions of short DNA reads were
generated by sequencing the RNA samples in individual
lanes of an Illumina 1.9 instrument (Illumina) by the Uni-
versity of Georgia Genomic Facility. Data were prepro-
cessed by first trimming the first 15 nucleotides from each
of the 5’ end of each of the reads and then using a sliding
window of size 3 and an average quality of 25 to trim both
ends of the reads. This was followed by a filtering step to
remove reads such that 80% or more nucleotides within a
read had a quality score greater than 20. FastQC was used
to examine the quality of the reads before and aftertrimming and indicates that on average all of the retained
reads were of average quality greater than 19 for all
samples. Paired end were matched and only lengths
greater than or equal to 75 nucleotides were used in the
following analyses.
RNA-Seq analysis of differential expression
The Tuxedo Suite [41–43] was used to evaluate the tran-
scriptome of BA3NI-I0, BA3NI-I6-PI, and BA3NI-I9 with
one sample obtained for each condition. All reads were
aligned to the Chicken (Gallus Gallus) genome ob-
tained from http://useast.ensembl.org/info/data/ftp/
index.html (last accessed July 29th 2016). The protocol
for differential gene expression analysis was published
elsewhere [43]. Briefly, we first built the indexed genome
using bowtie 2. Then, utilizing this genome and the anno-
tated genes, we first aligned the Illumina sequences using
TopHat 2 and assessed differential expression using Cuf-
flinks 2 (significance, p < 0.05). We used the commeRbund
package in R for visualization and further analysis.
Statistical analysis
Differences between mean n values were analyzed using
the Kruskal-Wallis test followed by the Dunn’s test for
multiple comparisons. Virus titers and cell counts over
time were analyzed using a two-way analysis of variance
(ANOVA) for repeated measures followed by a Tukey’s or
Sidak’s test for multiple comparisons. All tests were consid-
ered statistically significant for p values < 0.05. Statistical
analysis was carried out using GraphPad Prism for iOS,
version 7 (GraphPad Software, La Jolla California USA).
Additional files
Additional file 1: Table S1. List of differentially expressed genes between
BA3NI-I0 and BA3NI-I6 (average of biological triplicates). (XLSX 57 kb)
Additional file 2: Table S2. List of differentially expressed genes between
BA3NI-I6 and BA3NI-I9-C1 (average of biological triplicates). (XLSX 189 kb)
Additional file 3: Table S3. List of differentially expressed genes between
BA3NI-I0 and BA3NI-I9-C1 (average of biological triplicates). (XLSX 214 kb)
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